Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis, , , , , , , , , and 4 other author(s). Scientific Reports, (2018)Inflammation and Oxidative Stress in Multiple Sclerosis : Consequences for Therapy Development, , , , , and . Oxidative Medicine and Cellular Longevity, (2020)Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration, , , , , , , , , and 4 other author(s). Proceedings of the National Academy of Sciences, 113 (43): 12304--12309 (October 2016)Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS, , , , , , , , , and 3 other author(s). Journal of neuroinflammation, (2023)Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis, , , , , , , , , and 4 other author(s). Brain, Behavior and Immunity, (2019)Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration, , , , , , , , , and 4 other author(s). Proceedings of the National Academy of Sciences of the United States of America, 113 (43): 12304-12309 (2016)The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration, , , , , , , , , and 3 other author(s). Scientific reports, (2023)